Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0VH4T
|
|||
| Drug Name |
ONO-7475
|
|||
| Indication | Acute myeloid leukaemia [ICD-11: 2A60] | Phase 1 | [1] | |
| Company |
Ono Pharmaceutical Osaka, Japan
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Tyrosine-protein kinase Mer (MERTK) | Target Info | Inhibitor | [1] |
| Tyrosine-protein kinase UFO (AXL) | Target Info | Inhibitor | [1] | |
| NetPath Pathway | TSH Signaling Pathway | |||
| FSH Signaling Pathway | ||||
| Pathway Interaction Database | Validated transcriptional targets of deltaNp63 isoforms | |||
| Reactome | Cell surface interactions at the vascular wall | |||
| VEGFA-VEGFR2 Pathway | ||||
| WikiPathways | Cell surface interactions at the vascular wall | |||
| miR-targeted genes in squamous cell - TarBase | ||||
| miR-targeted genes in muscle cell - TarBase | ||||
| miR-targeted genes in lymphocytes - TarBase | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.